Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 13 von 18567

Details

Autor(en) / Beteiligte
Titel
A Selective Peroxisome Proliferator-Activated Receptor δ Agonist Promotes Reverse Cholesterol Transport
Ist Teil von
  • Proceedings of the National Academy of Sciences - PNAS, 2001-04, Vol.98 (9), p.5306-5311
Ort / Verlag
United States: National Academy of Sciences
Erscheinungsjahr
2001
Quelle
MEDLINE
Beschreibungen/Notizen
  • The peroxisome proliferator-activated receptors (PPARs) are dietary lipid sensors that regulate fatty acid and carbohydrate metabolism. The hypolipidemic effects of the fibrate drugs and the antidiabetic effects of the glitazone drugs in humans are due to activation of the α (NR1C1) and γ (NR1C3) subtypes, respectively. By contrast, the therapeutic potential of the δ (NR1C2) subtype is unknown, due in part to the lack of selective ligands. We have used combinatorial chemistry and structure-based drug design to develop a potent and subtype-selective PPARδ agonist, GW501516. In macrophages, fibroblasts, and intestinal cells, GW501516 increases expression of the reverse cholesterol transporter ATP-binding cassette A1 and induces apolipoprotein A1-specific cholesterol efflux. When dosed to insulin-resistant middle-aged obese rhesus monkeys, GW501516 causes a dramatic dose-dependent rise in serum high density lipoprotein cholesterol while lowering the levels of small-dense low density lipoprotein, fasting triglycerides, and fasting insulin. Our results suggest that PPARδ agonists may be effective drugs to increase reverse cholesterol transport and decrease cardiovascular disease associated with the metabolic syndrome X.
Sprache
Englisch
Identifikatoren
ISSN: 0027-8424
eISSN: 1091-6490
DOI: 10.1073/pnas.091021198
Titel-ID: cdi_pnas_primary_98_9_5306

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX